1. Podcasts
  2. Squawk on the Street
  3. CNBC Investing Club: Cramer’s Morning Take on Goldman Sachs 10/14/26
Squawk on the Street

14 Oct 2026 · 4m · 4 chapters

Episode artwork

CNBC Investing Club: Cramer’s Morning Take on Goldman Sachs 10/14/26

In short

Jim Cramer previews his “morning take” for the CNBC Investing Club, focusing on market direction and specific stock/sector moves. He argues Larry Fink (BlackRock) is bullish on the need for new capital to power compute, linking it to the NVIDIA theme, but cautions that good earnings for a company (e.g., Goldman Sachs) may not immediately lift the stock in a choppy market. He highlights Goldman Sachs as having the best story/vision among major banks, while noting Goldman’s results were strong yet the stock was slightly negative. He mentions Wells down ~3%, Bank of America dragged by weakness, and Bank of America’s regulatory “OCC” issue as a $1B fine. He cites positive catalysts in healthcare: Procter & Gamble strength and Cardinal Health surging after renewing a CVS contract; he also notes Danaher rebounding as biotech investment expectations rise.

Guests

No named guests; it’s Cramer’s solo preview referencing “today’s members-only CNBC Investing Club morning meeting” and “David” (unnamed).

Written by AI. May contain mistakes.

Chapters

1:21

Larry Fink's Market Insights

Jim Cramer shares insights on Larry Fink's bullish market theories and implications for capital investment.

“I have to tell you, I was quite struck by Larry Fink today.”
2:45

Goldman Sachs Analysis

Cramer discusses Goldman Sachs' performance and its potential as a strong investment choice.

“Down again today, I think it's just dragged by Bank of America, which was the worst of the group.”
3:11

Stock Market Trends and Catalysts

Cramer examines current market trends and key companies like Procter & Gamble and Cardinal Health.

“I do think that today is an outlying day because when I see a Procter & Gamble highlight.”
4:02

Disclaimer on Cramer's Opinions

Understanding the nature of Jim Cramer's opinions and their implications for investors.

“No specific outcome or profit is guaranteed in connection with your reliance upon or other use of the content from Kramer.”
A man walking through an airport, asking his phone a question

Ask about this episode

Get the gist, explore an idea or ask about something said.

Claude

On Squawk on the Street, what are the key points of this episode?

Searching your listening

Transcript

Automatic transcript. May contain errors.

0:02At Janus Henderson Investors, we believe working together is the way to work better. Like combining your portfolio plans and our in-depth strategy, your valued assets and our valuable insights, your vision and our mission, working in harmony to seek the right investment opportunities. Janus Henderson Investors, investing in a brighter future together. weren't agents supposed to take things off your plate? Building another to handle the others is a bit much. Don't make more work out of work. Gemini is the one agent that knows all parts of your business and actually gets stuff done. You give it a project, close your laptop, and when you come back, the job's finished.

0:47No matter your industry or role, your agent has the skills to help every team stay in their flow. Seriously, make work less work with Gemini on Google Cloud. Check response, subscription required. Jim Cramer here to share a short preview of my take on the market from today's members-only CNBC Investing Club morning meeting. Join the club for full access to the morning meeting every day at 1020 a.m. Visit CNBC.com slash morning take to sign up today. That's one word, morning take. I have to tell you, I was quite struck by Larry Fink today. I'm obviously smarting that we're in Bank of New York, which collapsed for no particular reason.

1:30The report tomorrow, don't want to touch it until then. But Larry Fink was talking and was creating a bullish theory about the need for capital and how he's going to be able to provide new capital for compute. That is the NVIDIA case. He's getting the case of NVIDIA, what's going to happen. And I don't even want to say go buy NVIDIA because we're in a market that's fraught. And good news for an individual stock is not necessarily going to translate right now into a stock that goes higher. Yeah, like even Goldman Sachs reported great numbers yesterday. Struggling to, I think at the end of the day, slightly negative.

2:09Even it was probably the best IB of the bunch this quarter between Morgan Stanley. Oh, it was the best. I spoke to David last yesterday. And it's been hit hard. And I would, and that's one of the stocks I want to highlight tomorrow, because I get to speak, I'm lucky enough to be able to get to speak to a lot of these executives. And of the ones that I thought had the best story, the best vision, it was Goldman Sachs. By the way, by far. No, I mean, Jamie Dimes is not close to him at JP Morgan. So I do think that that is the one you want to buy. Wells fell 3 % today. Down again today, I think it's just dragged by Bank of America, which was the worst of the group.

2:52Right. And Bank of America was always supposed to be the most, let's say, boring and boring being good. But not this time. Don't worry about the OCC thing. That was just something, the billion-dollar fine. Look, they admitted to doing something. They didn't want to fight the regulators. It's not where you want to be. I do think that today is an outlying day because when I see a Procter & Gamble highlight. Positive catalyst. Positive catalyst. And I see Cardinal Health, this once again, just screaming higher. Yeah. I say to myself, okay, take a deep breath. Do you want to own Cardinal Health? If you were a trader, you'd sell a Cardinal.

3:33Yeah. Cardinal Health really taken off the group has since they renewed that contract with CVS, which we highlighted. And this is the best one. Remember, we bought this, you know, we got victimized by this. Yeah. But here we go. The only one that's really come back from when we sold it was Danaher that's coming back. Yeah. And Danaher's because that whole cohort's coming back because people feel that there's going to be more investment by biotechs because there's so many biotechs coming public. All opinions expressed by Jim Cramer on this podcast and in connection with the CNBC Investing Club are solely Cramer's opinions and do not reflect the opinions of CNBC or its parent company or affiliates, and may have been previously disseminated by Kramer on television, radio, internet, or another medium.

4:15No specific outcome or profit is guaranteed in connection with your reliance upon or other use of the content from Kramer. The opinions offered in connection with this podcast and the CNBC Investing Club are not an attempt to induce any particular trading behavior, investment, or strategy. To view the full CNBC Investing Club disclaimer, please visit cnbc.com forward slash investing club disclaimer. At Jared Jewelers, we know it's about more than fine jewelry. It's the moment they open the box. That smile they can't hide. Knowing you chose exactly right. Because the right gift can bring a lifetime of meaning.

4:49A promise. A milestone. A memory in the making. Make every moment unforgettable. Find great gifts starting at$250. Jared, make the holiday last forever. Shop Jared Jewelers. you

From the publisher

Cramer says this financial firm is the one investors want to buy. Become an Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks every day as they talk candidly about the market’s biggest headlines, analyst calls and holdings in the Charitable Trust – and see up close how they decide when, and if, to take action on stocks. Sign up here:  cnbc.com/morningtake


 

CNBC Investing Club Disclaimer


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More from Squawk on the Street

All episodes